Albers Jeffrey W. Insider Trades

Insider Trading History

Track insider trading activity for Albers Jeffrey W.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $630k 8,026 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$582k 8,026 shares
$72.51
$78.48
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $373k 5,000 shares
Last Trade
Dec 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$333k 5,000 shares
$66.62
$74.61
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $522k 7,000 shares
Last Trade
Dec 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$333k 5,000 shares
$66.62
$74.61
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $168k 2,252 shares
Last Trade
Dec 08, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$333k 5,000 shares
$66.62
$74.61
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $373k 5,000 shares
Last Trade
Oct 13, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$299k 5,000 shares
$59.89
$74.61
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $0 0 shares
Last Trade
Oct 13, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$299k 5,000 shares
$59.89
$74.61
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $0 0 shares
Last Trade
Oct 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$296k 5,000 shares
$59.19
$74.61
Blueprint Medicines
Blueprint Medicines BPMC
Director
Holding Value $18.7M 144,755 shares
Last Trade
Jul 17, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$74.3M 573,647 shares
$129.46
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
Director
Holding Value $0 0 shares
Last Trade
Jul 17, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$18.7M 144,755 shares
$129.46
$129.46
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.19M 16,000 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$744k 16,000 shares
$46.47
$74.61
Blueprint Medicines
Blueprint Medicines BPMC
Director
Holding Value $19.5M 150,532 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 3,902 shares
$128.12
$129.46
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $0 0 shares
Last Trade
Jun 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$277k 6,349 shares
$43.58
$74.61
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $474k 6,349 shares
Last Trade
Jun 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$277k 6,349 shares
$43.58
$74.61
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $373k 5,000 shares
Last Trade
Jun 03, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$277k 6,349 shares
$43.58
$74.61
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $1.96M 25,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$389k 25,000 shares
$15.55
$78.48
Blueprint Medicines
Blueprint Medicines BPMC
Director
Holding Value $19.1M 147,280 shares
Last Trade
May 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$506k 5,000 shares
$101.14
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
Director
Holding Value $19.6M 151,630 shares
Last Trade
May 27, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$500k 5,000 shares
$100.06
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
Director
Holding Value $12M 92,500 shares
Last Trade
May 27, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$500k 5,000 shares
$100.06
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
Director
Holding Value $12.6M 97,500 shares
Last Trade
Mar 12, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$679k 7,500 shares
$90.50
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
Director
Holding Value $20.7M 159,896 shares
Last Trade
Mar 12, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$679k 7,500 shares
$90.50
$129.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up